Status:
COMPLETED
Factors Associated With Successful Completion of MRI in Children Undergoing a Vigil Sedation With Dexmedetomidin
Lead Sponsor:
Centre Hospitalier Régional Metz-Thionville
Conditions:
Procedural Sedation
EEG
Eligibility:
All Genders
3-18 years
Brief Summary
This is a retrospective cohort study aiming to determine whether the use of Dexmedetomidine (DEX) to sedate children prior to MRI scanning is more or less effective in children with autism spectrum di...
Detailed Description
Performing brain MRI on children under 5, or in cases of autism or disability, is often complex. In fact, this examination requires total immobilization of the child for at least 20 minutes. The noise...
Eligibility Criteria
Inclusion
- patients under 18 years of age sedated with DEX IN prior to MRI.
Exclusion
- incomplete or missing medical records
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2024
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT06203522
Start Date
January 1 2024
End Date
March 30 2024
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHR Metz-Thionville/Hopital Mercy
Metz, France, 57085